Skip to main content

Advertisement

Table 2 Studies reporting adjusted odds ratios for mortality in urinary LAM-positive compared to urinary LAM-negative TB cases, after adjustment for other predictors of mortality

From: Detection of lipoarabinomannan (LAM) in urine is an independent predictor of mortality risk in patients receiving treatment for HIV-associated tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis

Study Study setting and population Adjusted odds ratio for mortality in urinary LAM-positive compared to urinary LAM-negative TB cases (95 % CI) Variables included in the multivariable analysis with urinary LAM status
Talbot et al. (2012) [49] Hospital inpatients; TB suspected 1.3 (0.9–1.8) CD4 cell count, ART
Drain et al. (2015) [52] Outpatients; confirmed TB patients 5 (1.1–23.9) CD4 cell count, age, gender, Karnofsky score
Peter et al. (2015) [53] Hospital inpatients; TB suspected 4.7 (1.6–15.9) Study site, gender, age, CD4 cell count
Lawn et al. (2015) [54] Hospital inpatients; All HIV+ patients 4.2 (1.5–11.8) Age, CD4 cell count
Bjerrum et al. (2015) [55] Hospital inpatients and outpatients; TB suspected 2.2 (1.1–3.5) Gender, hospitalisation, CD4 cell count, Medical Early Warning Score
  1. ART antiretroviral therapy, CI confidence interval, LAM lipoarabinomannan, TB tuberculosis